Progress in elucidating the pathophysiological basis of nonrapid eye movement parasomnias: Not yet informing therapeutic strategies

Nature and Science of Sleep

Volumn 8, Issue , 2016, Pages 73-79

  Horváth, András ^a,b   Papp, Anikó ^a   Szcs, Anna ^a  

^a National Institute of Clinical Neuroscience   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Arousal disorders; NREM parasomnia; Sleep disorders; Sleep terror; Sleepwalking

Indexed keywords

EID: 84979633616     PISSN: None     EISSN: 11791608     Source Type: Journal    
DOI: 10.2147/NSS.S71513     Document Type: Review

References (109)

1. Broughton RJ. Sleep disorders: disorders of arousal? Enuresis, somnambulism, and nightmares occur in confusional states of arousal, not in dreaming sleep. Science. 1968;159(3819):1070-1078.
2. Medicine AAoS. Diagnostic and Coding Manual. Westchester, IL: American Academy of Sleep Medicine. International Classification of Sleep Disorders; 2005.
3. Uguccioni G, Golmard JL, de Fontréaux AN, Leu-Semenescu S, Brion A, Arnulf I. Fight or flight? Dream content during sleepwalking/sleep terrors vs rapid eye movement sleep behavior disorder. Sleep Med. 2013;14(5):391-398.
4. Dumitrascu O, Schenck CH, Applebee G, Attarian H. Parasomnia overlap disorder: a distinct pathophysiologic entity or a variant of rapid eye movement sleep behavior disorder? A case series. Sleep Med. 2013; 14(11):1217-1220.
5. Manni R, Terzaghi M. Dreaming and enacting dreams in nonrapid eye movement and rapid eye movement parasomnia: a step toward a unifying view within distinct patterns? Sleep Med. 2013;14(5):387-388.
6. Bhat S, Chokroverty S, Kabak B, Yang QR, Rosen D. Dream-enacting behavior in non-rapid eye movement sleep. Sleep Med. 2012;13(4): 445-446.
7. Ohayon MM, Mahowald MW, Dauvilliers Y, Krystal AD, Léger D. Prevalence and comorbidity of nocturnal wandering in the US adult general population. Neurology. 2012;78(20):1583-1589.
8. Bjorvatn B, Grønli J, Pallesen S. Prevalence of different parasomnias in the general population. Sleep Med. 2010;11(10):1031-1034.
9. Brion A, Flamand M, Oudiette D, Voillery D, Golmard J-L, Arnulf I. Sleep-related eating disorder versus sleepwalking: a controlled study. Sleep Med. 2012;13(8):1094-1101.
10. Organ A, Fedoroff JP. Sexsomnia: sleep sex research and its legal implications. Curr Psychiatry Rep. 2015;17(5):1-8.
11. Zadra A, Pilon M, Montplaisir J. Polysomnographic diagnosis of sleepwalking: effects of sleep deprivation. Ann Neurol. 2008;63(4): 513-519.
12. Pressman MR. Factors that predispose, prime and precipitate NREM parasomnias in adults: clinical and forensic implications. Sleep Med Rev. 2007;11(1):5-30.
13. Siclari F, Khatami R, Urbaniok F, et al. Violence in sleep. Brain. 2010; 133(12):3494-3509.
14. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System of Sleep Stages in Human Subjects. Los Angeles: Brain Information Service/Brain Research Institute, University of California; 1968.
15. Carskadon MA, Rechtschaffen A. Monitoring and staging human sleep. In: Kryger M, Roth T, Dement WC, editors. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia: WB Saunders; 2000:1203-1206.
16. Parrino L, Halasz P, Tassinari CA, Terzano MG. CAP, epilepsy and motor events during sleep: the unifying role of arousal. Sleep Med Rev. 2006;10(4):267-285.
17. Terzano M, Mancia D, Salati M, Costani G, Decembrino A, Parrino L. The cyclic alternating pattern as a physiologic component of normal NREM sleep. Sleep. 1985;8:137-145.
18. Halasz P, Bodizs R. Dynamic Structure of NREM Sleep. London: Springer Science and Business Media; 2012.
19. Terzano MG, Parrino L, Sherieri A, et al. Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern (CAP) in human sleep. Sleep Med. 2001;2(6):537-553.
20. Bordas C, Kovacs A, Pal B. The M-current contributes to high threshold membrane potential oscillations in a cell type-specific way in the pedunculopontine nucleus of mice. Front Cell Neurosci. 2015;9:121.
21. Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 2001;24(12): 726-731.
22. Kohlmeier KA, Tyler CJ, Kalogiannis M, et al. Differential actions of orexin receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor knockouts: implications for orexinergic signaling in arousal and narcolepsy. Front Neurosci. 2013;7:246.
23. Ishibashi M, Gumenchuk I, Kang B, et al. Orexin receptor activation generates gamma band input to cholinergic and serotonergic arousal system neurons and drives an intrinsic Ca2+-dependent resonance in LDT and PPT cholinergic neurons. Front Neurol. 2015;6:120.
24. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573-585.
25. Yamanaka A, Beuckmann CT, Willie JT, et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron. 2003;38(5):701-713.
26. American Academy of Sleep Medicine. International Classification of Sleep Disorders-third edition (ICSD-3). AASM Resource Library; 2014.
27. Oluwole O. Lifetime prevalence and incidence of parasomnias in a population of young adult Nigerians. J Neurol. 2010;257(7):1141-1147.
28. Abe K, Shimakawa M. Predisposition to sleep-walking. Psychiatr Neurol (Basel). 1966;152(5):306-312.
29. Abe K, Amatomi M, Oda N. Sleepwalking and recurrent sleeptalking in children of childhood sleepwalkers. Am J Psychiatry. 1984;141:800-801.
30. Kales A, Soldatos CR, Bixler E, et al. Hereditary factors in sleepwalking and night terrors. Br J Psychiatry. 1980;137(2):111-118.
31. Bakwin H. Sleep-walking in twins. Lancet. 1970;296(7670): 446-447.
32. Hublin C, Kaprio J. Genetic aspects and genetic epidemiology of parasomnias. Sleep Med Rev. 2003;7(5):413-421.
33. Dauvilliers Y, Maret S, Tafti M. Genetics of normal and pathological sleep in humans. Sleep Med Rev. 2005;9(2):91-100.
34. Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol. 2003;114:2000-2017.
35. Ferri R, Miano S, Bruni O, et al. NREM sleep alterations in narcolepsy/cataplexy. Clin Neurophysiol. 2005;116:2675-2684.
36. Plazzi G, Serra L, Ferri R. Nocturnal aspects of narcolepsy with cataplexy. Sleep Med Rev. 2008;12:109-128.
37. Mayer G, Meier-Ewert K. Motor dyscontrol in sleep of narcoleptic patients (a lifelong development?). J Sleep Res. 1993;2:143-148.
38. Lecendreux M, Bassetti C, Dauvilliers Y, Mayer G, Neidhart E, Tafti M. HLA and genetic susceptibility to sleepwalking. Mol Psychiatry. 2003;8(1):114-117.
39. Popat S, Winslade W. While you were sleepwalking: science and neurobiology sleep disorders and the enigma of legal responsibility of violence during parasomnia. Neuroethics. 2015;8(2):203-214.
40. Szcs A, Kamondi A, Zoller R, Barcs G, Szabó P, Purebl G. Violent somnambulism: a parasomnia of young men with stereotyped dream-like experiences. Med Hypotheses. 2014;83(1):47-52.
41. De la Herrán-Arita AK, Kornum BR, Mahlios J, et al. CD4+T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 Influenza A epitope in narcolepsy. Sci Transl Med. 2013;5(216):216ra176.
42. Gough S, Simmonds MJ. The HLA region and autoimmune disease: associations and mechanisms of action. Curr Genomics. 2007;8(7): 453-465.
43. Hosomichi K, Shiina T, Tajima A, Inoue I. The impact of next-generation sequencing technologies on HLA research. J Hum Genet. 2015:665-673.
44. Licis A, Desruisseau D, Yamada K, Duntley S, Gurnett C. Novel genetic findings in an extended family pedigree with sleepwalking. Neurology. 2011;76(1):49-52.
45. Provini F, Plazzi G, Tinuper P, Vandi S, Lugaresi E, Montagna P. Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. Brain. 1999;122(6):1017-1031.
46. Bisulli F, Vignatelli L, Naldi I, et al. Increased frequency of arousal parasomnias in families with nocturnal frontal lobe epilepsy: a common mechanism? Epilepsia. 2010;51(9):1852-1860.
47. Tinuper P, Provini F, Bisulli F, Lugaresi E. Hyperkinetic manifestations in nocturnal frontal lobe epilepsy. Semeiological features and physiopathological hypothesis. Neurol Sci. 2005;26(3):s210-s214.
48. Tassinari CA, Gardella E, Cantalupo G, Rubboli G. Relationship of central pattern generators with parasomnias and sleep-related epileptic seizures. Sleep Med Clin. 2012;7(1):125-134.
49. Oldani A, Zucconi M, Asselta R, et al. Autosomal dominant nocturnal frontal lobe epilepsy. Brain. 1998;121:205-223.
50. Montagna P, Provini F, Bisulli F, Tinuper P. Nocturnal epileptic seizures versus the arousal parasomnias. Somnologie (Berl). 2008;12(1):25-37.
51. Jaar O, Pilon M, Carrier J, Montplaisir J, Zadra A. Analysis of slow-wave activity and slow-wave oscillations prior to somnambulism. Sleep. 2010;33(11):1511-1516.
52. Derry CP, Harvey AS, Walker MC, Duncan JS, Berkovic SF. NREM arousal parasomnias and their distinction from nocturnal frontal lobe epilepsy: a video EEG analysis. Sleep. 2009;32(12):1637-1644.
53. Zucconi M, Ferini-Strambi L. NREM parasomnias: arousal disorders and differentiation from nocturnal frontal lobe epilepsy. Clin Neurophysiol. 2000;111:S129-S135.
54. Zucconi M, Oldani A, Ferini-Strambi L, Bizzozero D, Smirne S. Nocturnal paroxysmal arousals with motor behaviors during sleep: frontal lobe epilepsy or parasomnia? J Clin Neurophysiol. 1997;14(6): 513-522.
55. Halász P, Kelemen A, Szcs A. Physiopathogenetic interrelationship between nocturnal frontal lobe epilepsy and NREM arousal parasomnias. Epilepsy Res Treat. 2012; 2012:312693.
56. Desautels A, Zadra A, Labelle M-A, Dauvilliers Y, Petit D, Montplaisir J. Daytime somnolence in adult sleepwalkers. Sleep Med. 2013;14(11): 1187-1191.
57. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123(2):331-339.
58. Ylikoski A, Martikainen K, Partinen M. Parasomnias and isolated sleep symptoms in Parkinson's disease: a questionnaire study on 661 patients. J Neurol Sci. 2014;346(1):204-208.
59. Barabas G, Ferrari M, Matthews WS. Childhood migraine and somnambulism. Neurology. 1983;33:948-949.
60. Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45(7):904-910.
61. Lippman CW. Recurrent dreams in migraine: an aid to diagnosis. J Nerv Ment Dis. 1954;120(3-4):273-276.
62. Cevoli S, Giannini G, Favoni V, Pierangeli G, Cortelli P. Migraine and sleep disorders. Neurol Sci. 2012;33(1):43-46.
63. Fernandes G, Franco AL, Gonçalves DA, Speciali JG, Bigal ME, Camparis CM. Temporomandibular disorders, sleep bruxism, and primary headaches are mutually associated. J Orofac Pain. 2013;27(1): 14-20.
64. Miller V, Palermo T, Powers S, Scher M, Hershey A. Migraine headaches and sleep disturbances in children. Headache. 2003;43(4):362-368.
65. Terron JA. Is the 5-HT7 receptor involved in the pathogenesis and prophylactic treatment of migraine? Eur J Pharmacol. 2002;439:1-11.
66. Cape EG, Jones BE. Differential modulation of high-frequency electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons. J Neurosci. 1998;18(7):2653-2666.
67. Kales JD, Kales A, Soldatos CR, Chamberlin K, Martin ED. Sleepwalking and night terrors related to febrile illness. Am J Psychiatry. 1979;136(9):1214-1215.
68. Kawashima T, Yamada S. Paroxetine-induced somnambulism. J Clin Psychiatry. 2003;64(4):483.
69. Landry P, Warnes H, Nielsen T, Montplaisir J. Somnambulistic-like behaviour in patients attending a lithium clinic. Int Clin Psychopharmacol. 1999;14(3):173-176.
70. Price LH, Charney DS, Delgado PL, Heninger GR. Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology. 1990;100(1):3-12.
71. Juszczak GR, Swiergiel AH. Serotonergic hypothesis of sleepwalking. Med. Hypotheses. 2005;64(1):28-32.
72. Celesia GG, Jasper HH. Acetylcholine released from cerebral cortex in relation to state of activation. Neurology. 1966;16(11):1053-1053.
73. Muzur A, Pace-Schott EF, Hobson JA. The prefrontal cortex in sleep. Trends Cogn Sci. 2002;6(11):475-481.
74. Montplaisir JY. Cholinergic mechanisms involved in cortical activation during arousal. Electroenceph Clin Neurophysiol. 1975;38(3): 263-272.
75. Shiba Y, Mori F, Yamada J, et al. Spontaneous epileptic seizures in transgenic rats harboring a human ADNFLE missense mutation in the 2-subunit of the nicotinic acetylcholine receptor. Neurosci Res. 2015;100:46-54.
76. Itier V, Bertrand D. Mutations of the neuronal nicotinic acetylcholine receptors and their association with ADNFLE. Neurophysiol Clin. 2002;32(2):99-107.
77. Aridon P, Marini C, Di Resta C, et al. Increased sensitivity of the neuronal nicotinic receptor 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet. 2006;79(2):342-350.
78. Becchetti A, Aracri P, Meneghini S, Brusco S, Amadeo A. The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy. Front Physiol. 2015;6:22.
79. Halász P, Kelemen A, Szcs A. The role of NREM sleep micro-arousals in absence epilepsy and in nocturnal frontal lobe epilepsy. Epilepsy Res. 2013;107(1):9-19.
80. Hogan RE, Kaiboriboon K. The dreamy state: John Hughlings-Jackson's ideas of epilepsy and consciousness. Am J Psychiatry. 2003; 160(10):1740-1747.
81. Tassinari CA, Rubboli G, Gardella E, et al. Central pattern generators for a common semiology in fronto-limbic seizures and in parasomnias. A neuroethologic approach. Neurol Sci. 2005;26(3):225-232.
82. Petrovic J, Lazic K, Ciric J, Kalauzi A, Saponjic J. Topography of the sleep/wake states related EEG microstructure and transitions structure differentiates the functionally distinct cholinergic innervation disorders in rat. Behav Brain Res. 2013;256:108-118.
83. Mahowald MW, Schenck CH. Status dissociatus: a perspective on states of being. Sleep. 1991;14(1):69-79.
84. Meletti S, Vaudano AE, Pizza F, et al. The brain correlates of laugh and cataplexy in childhood narcolepsy. J Neurosci. 2015;35(33): 11583-11594.
85. Krueger JM, Obál F, Kapás L, Fang J. Brain organization and sleep function. Behav Brain Res. 1995;69(1):177-185.
86. Kattler H, Dijk DJ, Borbely AA. Effect of unilateral somatosensory stimulation prior to sleep on the sleep EEG in humans. J Sleep Res. 1994;3(3):159-164.
87. Mukhametov L, Supin AY, Polyakova I. Interhemispheric asymmetry of the electroencephalographic sleep patterns in dolphins. Brain Res. 1977;134(3):581-584.
88. Bassetti C, Vella S, Donati F, Wielepp P, Weder B. SPECT during sleepwalking. Lancet. 2000;356(9228):484-485.
89. Gibbs SA, Proserpio P, Terzaghi M, et al. Sleep-related epileptic behaviors and non-REM-related parasomnias: insights from stereo-EEG. Sleep Med Rev. Epub 2015 May 19.
90. Borbély AA, Achermann P. Sleep homeostasis and models of sleep regulation. J Biol Rhythms. 1999;14(6):559-570.
91. Guilleminault C, Palombini L, Pelayo R, Chervin RD. Sleepwalking and sleep terrors in prepubertal children: what triggers them? Pediatrics. 2003;111(1):e17-e25.
92. Ohayon MM, Guilleminault C, Priest RG. Night terrors, sleepwalking, and confusional arousals in the general population: their frequency and relationship to other sleep and mental disorders. J Clin Psychiatry. 1999;60(4):268-276.
93. Ajlouni KM, Ahmad AT, Al-Zahiri MM, et al. Sleepwalking associated with hyperthyroidism. Endocr Pract. 2005;11(1):5-10.
94. Di Gennaro G, Autret A, Mascia A, Onorati P, Sebastiano F, Quarato PP. Night terrors associated with thalamic lesion. Clin Neurophysiol. 2004;115(11):2489-2492.
95. Owens J, Spirito A, Nobile C, Arrigan M. Incidence of parasomnias in children with obstructive sleep apnea. Sleep. 1997;20(12): 1193-1196.
96. Guilleminault C, Kirisoglu C, Bao G, Arias V, Chan A, Li KK. Adult chronic sleepwalking and its treatment based on polysomnography. Brain. 2005;128(5):1062-1069.
97. Kotagal S. Parasomnias in childhood. Sleep Med Rev. 2009;13(2): 157-168.
98. Hossain JL, Shapiro CM. The prevalence, cost implications, and management of sleep disorders: an overview. Sleep Breath. 2002;6(2): 85-102.
99. Wilson SJ, Nutt D, Alford C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24(11):1577-1601.
100. Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA. 2006;295(24):2851-2858.
101. Hurwitz TD, Mahowald MW, Schenck CH, Schluter JL, Bundlie SR. A retrospective outcome study and review of hypnosis as treatment of adults with sleepwalking and sleep terror. J Nerv Ment Dis. 1991;179(4):228-233.
102. Tobin JD. Treatment of somnambulism with anticipatory awakening. J Pediatr. 1993;122(3):426-427.
103. Harris M, Grunstein RR. Treatments for somnambulism in adults: assessing the evidence. Sleep Med Rev. 2009;13(4):295-297.
104. Reid W, Haffke E, Chu CC. Diazepam in intractable sleepwalking: a pilot study. Hillside J Clin Psychiatry. 1983;6(1):49-55.
105. Schenck CH, Mahowald MW. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med. 1996;100(3):333-337.
106. Kierlin L, Littner MR. Parasomnias and antidepressant therapy: a review of the literature. Front Psychiatry. 2011;2:71.
107. Cooper AJ. Treatment of coexistent night-terrors and somnambulism in adults with imipramine and diazepam. J Clin Psychiatry. 1987;48(5): 209-210.
108. Lillywhite A, Wilson S, Nutt D. Successful treatment of night terrors and somnambulism with paroxetine. Br J Psychiatry. 1994;164(4): 551-554.
109. Lam SP, Fong S, Ho C, Yu M, Wing YK. Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study. J Clin Psychiatry. 2008;69(9):1374-1382.